MedPath

Carbamazepine

Generic Name
Carbamazepine
Brand Names
Carbatrol, Carnexiv, Epitol, Equetro, Tegretol
Drug Type
Small Molecule
Chemical Formula
C15H12N2O
CAS Number
298-46-4
Unique Ingredient Identifier
33CM23913M

Overview

Carbamazepine, also known as Tegretol, is an anticonvulsant drug and analgesic drug used to control seizures and to treat pain resulting from trigeminal neuralgia. It was initially approved by the FDA in 1965. Aside from the above uses, this drug is also given to control the symptoms of bipolar 1. Interestingly, carbamazepine was the first anticonvulsant used to treat individuals with bipolar disorder.

Background

Carbamazepine, also known as Tegretol, is an anticonvulsant drug and analgesic drug used to control seizures and to treat pain resulting from trigeminal neuralgia. It was initially approved by the FDA in 1965. Aside from the above uses, this drug is also given to control the symptoms of bipolar 1. Interestingly, carbamazepine was the first anticonvulsant used to treat individuals with bipolar disorder.

Indication

Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia. In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures. Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder. Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome.

Associated Conditions

  • Acute Mania
  • Alcohol Withdrawal Syndrome
  • Complex Partial Seizure Disorder
  • Generalized Tonic-Clonic Seizures
  • Mixed manic depressive episode
  • Pain
  • Partial Seizures With Secondary Generalization
  • Restless Legs Syndrome (RLS)

FDA Approved Products

Carbamazepine
Manufacturer:PAI Holdings, LLC
Route:ORAL
Strength:100 mg in 5 mL
Approved: 2023/01/13
NDC:0121-0947
Carbamazepine
Manufacturer:PAI Holdings, LLC
Route:ORAL
Strength:200 mg in 10 mL
Approved: 2023/01/13
NDC:0121-1894
Carbamazepine
Manufacturer:A-S Medication Solutions
Route:ORAL
Strength:200 mg in 1 1
Approved: 2018/06/01
NDC:50090-0384
Carbamazepine
Manufacturer:NCS HealthCare of KY, LLC dba Vangard Labs
Route:ORAL
Strength:100 mg in 1 1
Approved: 2022/08/16
NDC:0615-8125
Carbamazepine
Manufacturer:Apotex Corp.
Route:ORAL
Strength:300 mg in 1 1
Approved: 2023/05/09
NDC:60505-2807

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath